Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI

Tumor Associated Neutrophils as a Biomarker of Chemo-immunotherapy Response in Locally Advanced Non-small Cell Lung Cancer : a Model Based on Neoadjuvant Strategy

NCT06974097 ·Status: NOT_YET_RECRUITING

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

NCT03073902 ·Status: COMPLETED

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

NCT02202655 ·Status: UNKNOWN

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

NCT07256002 ·Status: ACTIVE_NOT_RECRUITING

Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer

NCT04187768 ·Status: COMPLETED

PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy

NCT02035683 ·Status: UNKNOWN ·Phase: NA

Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers

NCT03658460 ·Status: COMPLETED

Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab

NCT05027165 ·Status: UNKNOWN

Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer

NCT05928299 ·Status: COMPLETED

PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer

NCT05533086 ·Status: UNKNOWN

Imaging Biomarkers for Immune Checkpoint Inhibitor Treatment in Patients With Non-small Cell Lung Cancer

NCT05260606 ·Status: RECRUITING

Role of Cancer-associated Fibroblast, MDSCs and Immune Cell Interplays in the Resistance of Non-small Cell Lung Cancer to Anti-PD1/PD-L1 Therapies

NCT06024538 ·Status: NOT_YET_RECRUITING

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

NCT04566432 ·Status: RECRUITING

Identification of a Predictive Metabolic Signature of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

NCT04189679 ·Status: COMPLETED

The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer

NCT05082636 ·Status: COMPLETED

Influence of the Use of the Diabetic Drug Metformin on the Overall Survival and Treatment-related Toxicity in Advanced Stage Non-small Cell Lung Cancer Patients.

NCT02109549 ·Status: COMPLETED

Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

NCT06954259 ·Status: ACTIVE_NOT_RECRUITING

Local and Peripheral Immune Responsive Landscape Induced by Local Cryoablation in Patients With Lung Adenocarcinoma

NCT06104709 ·Status: NOT_YET_RECRUITING

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

NCT01004601 ·Status: COMPLETED ·Phase: NA

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

NCT05902260 ·Status: COMPLETED ·Phase: NA

cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

NCT04069442 ·Status: WITHDRAWN

Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC

NCT04586465 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 ·Status: COMPLETED

Metformin in Stage IV Lung Adenocarcinoma

NCT01997775 ·Status: TERMINATED ·Phase: PHASE2

Care Needs in Lung Cancer Patients Receiving Immunotherapy

NCT06433206 ·Status: RECRUITING